87 related articles for article (PubMed ID: 18653908)
1. N-myc downstream-regulated gene 1 as a downregulated target gene of PTEN in the controlling of tumourigenesis in endometrioid carcinoma.
Li S; Chen J; Yang Z; Lu G; Tang H; Hu H
Indian J Med Res; 2008 May; 127(5):453-9. PubMed ID: 18653908
[TBL] [Abstract][Full Text] [Related]
2. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
3. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
[TBL] [Abstract][Full Text] [Related]
4. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of Beclin1 and PTEN in endometrial carcinoma].
Zhao JH; Wan XY; Xie X; Zhou CY; Wu QY
Ai Zheng; 2006 Jun; 25(6):753-7. PubMed ID: 16764775
[TBL] [Abstract][Full Text] [Related]
6. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
[TBL] [Abstract][Full Text] [Related]
7. [Expression characteristics of PTEN and NDRG1 in colorectal carcinoma and their prognostic value].
Zhang GX; Qian ZY; Yang LJ; Wang F; Shen H
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):240-244. PubMed ID: 28376589
[No Abstract] [Full Text] [Related]
8. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
[TBL] [Abstract][Full Text] [Related]
10. [Possibility of PTEN expression on predicting pathologic risk factors of endometrioid adenocarcinoma before operation].
Lou HY; Lin kQ; Ye DF; Xie X; Yu X
Ai Zheng; 2005 Jun; 24(6):748-50. PubMed ID: 15946494
[TBL] [Abstract][Full Text] [Related]
11. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1.
Park KC; Menezes SV; Kalinowski DS; Sahni S; Jansson PJ; Kovacevic Z; Richardson DR
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2644-2663. PubMed ID: 29679718
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Ando T; Ishiguro H; Kimura M; Mitsui A; Kurehara H; Sugito N; Tomoda K; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Dis Esophagus; 2006; 19(6):454-8. PubMed ID: 17069588
[TBL] [Abstract][Full Text] [Related]
13. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].
Wang Y; Adila S; Zhang X; Dong Y; Li W; Zhou M; Li T
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):88-94. PubMed ID: 24742567
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations in endometrial cancers: relation to PTEN gene defects.
Janiec-Jankowska A; Konopka B; Goluda C; NajmoĊa U
Int J Gynecol Cancer; 2010 Feb; 20(2):196-202. PubMed ID: 20169661
[TBL] [Abstract][Full Text] [Related]
15. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
16. Expression of PTEN in endometrial liquid-based cytology.
Di Lorito A; Zappacosta R; Capanna S; Gatta DM; Rosini S; Schmitt FC
Acta Cytol; 2014; 58(5):495-500. PubMed ID: 25358681
[TBL] [Abstract][Full Text] [Related]
17. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the N-myc downstream regulated gene 1 is related to enhanced proliferation, invasion and migration of pancreatic cancer.
Cen G; Zhang K; Cao J; Qiu Z
Oncol Rep; 2017 Feb; 37(2):1189-1195. PubMed ID: 28075464
[TBL] [Abstract][Full Text] [Related]
19. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.
Minaguchi T; Yoshikawa H; Nakagawa S; Yasugi T; Yano T; Iwase H; Mizutani K; Shiromizu K; Ohmi K; Watanabe Y; Noda K; Nishiu M; Nakamura Y; Taketani Y
Cancer Lett; 2004 Jul; 210(1):57-62. PubMed ID: 15172121
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
